All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: Influenza A-30353004
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 30353004 K340R
PB2
PB2
Influenza A
G
S
C
L
View
2 30353004 R299K
PB2
PB2
Influenza A
G
S
C
L
View
3 30353004 R340K
PB2
PB2
Influenza A
G
S
C
L
View
4 30353004 H75P
PB1
PB1
Influenza A
G
S
C
L
View
5 30353004 R25Q
PB1
PB1
Influenza A
G
S
C
L
View
6 30353004 I668V
PA
PA
Influenza A
G
S
C
L
View
7 30353004 R15K
PA
PA
Influenza A
G
S
C
L
View
8 30353004 N127S
NS1
NS
Influenza A
G
S
C
L
View
9 30353004 D339N
NA
NA
Influenza A
G
S
C
L
View
10 30353004 K220N
NA
NA
Influenza A
G
S
C
L
View
11 30353004 N329S
NA
NA
Influenza A
G
S
C
L
View
12 30353004 V303I
NA
NA
Influenza A
G
S
C
L
View
13 30353004 I140T
HA1
HA
Influenza A
G
S
C
L
View
14 30353004 K92R
HA1
HA
Influenza A
G
S
C
L
View
15 30353004 N121K
HA1
HA
Influenza A
G
S
C
L
View
16 30353004 N171K
HA1
HA
Influenza A
G
S
C
L
View
17 30353004 R142K
HA1
HA
Influenza A
G
S
C
L
View
18 30353004 R261Q
HA1
HA
Influenza A
G
S
C
L
View
19 30353004 T114S
HA1
HA
Influenza A
G
S
C
L
View
20 30353004 T131K
HA1
HA
Influenza A
G
S
C
L
View
21 30353004 T135K
HA1
HA
Influenza A
G
S
C
L
View
22 30353004 T135N
HA1
HA
Influenza A
G
S
C
L
View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.